Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View up-to-date information on Alembic Pharmaceuticals Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 02 Jan 2023 | Alembic Pharmaceuticals Ltd Enters Phase I Clinical Trial Agreement with CBCC International Research LLC for doxorubicin hydrochloride (GDCT0475255) | Contract Service Agreement |
Alembic Pharmaceuticals Ltd
|
CBCC International Research LLC
|
| 13 Dec 2022 | Alembic Pharmaceuticals Ltd Enters Phase I Clinical Trial Agreement with Cliantha Research Ltd for paclitaxel (GDCT0474264) | Contract Service Agreement |
Alembic Pharmaceuticals Ltd
|
Cliantha Research Ltd
|
| 23 Nov 2022 | Aleor Dermaceuticals Ltd Enters Phase II Clinical Trial Agreement with Catawba Research LLC for tretinoin (GDCT0472791) | Contract Service Agreement |
Aleor Dermaceuticals Ltd
|
Catawba Research LLC
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer